The results are a blow to a fast-growing field that aims to catch cancer earlier, when treatment may be easier and more effective. HealthDay News — A blood test designed to find cancer early did not ...
Blood-based circulating tumor DNA (ctDNA) testing has proven to be insufficient for detecting KRAS mutations in patients with low-grade serous ovarian cancer (LGSOC), according to a study. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results